Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.36 |
| ▸ | MAPT | P10636 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | PTGS2 | P35354 | 2/20 | 0.33 |
| ▸ | RAPGEF4 | Q8WZA2 | 2/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.32 |
| ▸ | LMNA | P02545 | 2/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | XBP1 | P17861 | 1/20 | 0.32 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.31 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.31 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1044722 | 0.76 | MEN1 (0.47) | SMN1; SMN2MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL15132560 | 0.73 | FABP4 (0.37) | MAPTALDH1A1MEN1KMT2AALOX5 | |
| SCHEMBL17431932 | 0.70 | SMN1; SMN2 (0.35) | SMN1; SMN2MAPTRAPGEF4 | |
| SCHEMBL6382158 | 0.69 | ALDH1A1 (0.40) | SMN1; SMN2MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL15025688 | 0.66 | ADORA3 (0.40) | SMN1; SMN2MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL11966928 | 0.66 | ALDH1A1 (0.40) | SMN1; SMN2MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL9876053 | 0.65 | ALDH1A1 (0.50) | SMN1; SMN2MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL20872065 | 0.65 | KDM4E (0.52) | SMN1; SMN2MAPTALDH1A1KMT2APTGS2 | |
| SCHEMBL12622364 | 0.64 | PDGFRB (0.40) | SMN1; SMN2MAPTALDH1A1MEN1KMT2A | |
| SCHEMBL18165338 | 0.63 | RAPGEF4 (0.35) | SMN1; SMN2MAPTALDH1A1RAPGEF4LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8754241-B2 | Organic compound and electrochromic element having the same | CANON KABUSHIKI KAISHA (JP) | 2014-06-17 | — | — | US | disclosed |
| US-8754241-B2 | Organic compound and electrochromic element having the same | CANON KABUSHIKI KAISHA (JP) | 2014-06-17 | — | — | US | disclosed |
| US-20130190513-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT HAVING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-07-25 | — | — | US | disclosed |
| US-20130190513-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT HAVING THE SAME | CANON KABUSHIKI KAISHA (JP) | 2013-07-25 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20130190513-A1 | NOVEL ORGANIC COMPOUND AND ELECTROCHROMIC ELEMENT HAVING THE SAME | EPB41, CNOT1, CYP4F11 | SMN1; SMN2 2921/4885MAPT 3844/4885ALDH1A1 110/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.